Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/21665058/ below:

The effectiveness of the FLU-FOBT program in primary care a randomized trial

Randomized Controlled Trial

Affiliations

• ¹ Department of Family and Community Medicine, University of California San Francisco School of Medicine, 94143-0900, USA. potterm@fcm.ucsf.edu.

• PMID: 21665058
• DOI: 10.1016/j.amepre.2011.03.011

Item in Clipboard

Randomized Controlled Trial

Michael B Potter et al. Am J Prev Med. 2011 Jul.

• ¹ Department of Family and Community Medicine, University of California San Francisco School of Medicine, 94143-0900, USA. potterm@fcm.ucsf.edu.

• PMID: 21665058
• DOI: 10.1016/j.amepre.2011.03.011

Item in Clipboard

Background: The FLU-FOBT Program is an intervention in which nurses provide home fecal occult blood tests (FOBTs) to eligible patients during annual influenza vaccination (FLU) campaigns. The effectiveness of the FLU-FOBT Program when implemented during primary care visits has not been extensively studied.

Purpose: The effectiveness of the FLU-FOBT Program was tested as adapted for use during primary care visits in community clinics serving multiethnic patients with low baseline colorectal cancer (CRC) screening rates.

Design: Randomized clinical trial. During intervention weeks, nurses routinely initiated the offering of FOBT to eligible patients who were given FLU (FLU-FOBT group). During control weeks, nurses provided FOBT with FLU only when ordered by the primary care clinician during usual care (FLU-only group).

Setting/participants: The study was conducted in six community clinics in San Francisco. Participants were patients aged 50-75 years who received FLU during primary care visits during an 18-week intervention beginning on September 28, 2009.

Main outcome measures: The primary outcome was the change in CRC screening rates in the FLU-FOBT group compared to the FLU-only group at the end of the study period, on March 30, 2010. Multivariate logistic regression analysis was used to determine predictors of becoming up-to-date with CRC screening.

Results: Data were analyzed in 2010. A total of 695 participants received FLU on FLU-FOBT dates, and 677 received FLU on FLU-only dates. The CRC screening rate increased from 32.5% to 45.5% (+13.0 percentage points) in the FLU-FOBT group, and from 31.3% to 35.6% (+4.3 percentage points) in the FLU-only group (p=0.018 for change difference). For those due for CRC screening, the OR for completing CRC screening by the end of the measurement period was 2.22 (95% CI=1.24, 3.95) for the FLU-FOBT group compared to the FLU-only group.

Conclusions: FLU-FOBT Program participants were twice as likely to complete CRC screening as those receiving usual care. The FLU-FOBT Program is a practical strategy to increase CRC screening in community clinics. TRIAL REGISTRATION #: NCT01211379.

Copyright © 2011 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

• The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clinics.

  Potter MB, Somkin CP, Ackerson LM, Gomez V, Dao T, Horberg MA, Walsh J ME. Potter MB, et al. Am J Manag Care. 2011;17(8):577-83. Am J Manag Care. 2011. PMID: 21851145

• Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates.

  Potter MB, Phengrasamy L, Hudes ES, McPhee SJ, Walsh JM. Potter MB, et al. Ann Fam Med. 2009 Jan-Feb;7(1):17-23. doi: 10.1370/afm.934. Ann Fam Med. 2009. PMID: 19139445 Free PMC article. Clinical Trial.

• Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.

  Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, Lee JY, Cameron KA, Ferreira MR, Stephens Q, Goldman SN, Rademaker A, Wolf MS. Baker DW, et al. JAMA Intern Med. 2014 Aug;174(8):1235-41. doi: 10.1001/jamainternmed.2014.2352. JAMA Intern Med. 2014. PMID: 24934845 Clinical Trial.

• [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

  Quintero E. Quintero E. Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.

• [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].

  Takemasa I, Kikkawa N, Yasui M, Nishisho I, Fujitani K, Mishima H, Hasuike Y, Kobayashi K. Takemasa I, et al. Gan To Kagaku Ryoho. 1998 Aug;25(10):1514-8. Gan To Kagaku Ryoho. 1998. PMID: 9725042 Review. Japanese.

• Implementation of an evidence-based intervention to promote colorectal cancer screening in community organizations: a cluster randomized trial.

  Maxwell AE, Danao LL, Cayetano RT, Crespi CM, Bastani R. Maxwell AE, et al. Transl Behav Med. 2016 Jun;6(2):295-305. doi: 10.1007/s13142-015-0349-5. Transl Behav Med. 2016. PMID: 27282431 Free PMC article. Clinical Trial.

• A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.

  Davis SN, Christy SM, Chavarria EA, Abdulla R, Sutton SK, Schmidt AR, Vadaparampil ST, Quinn GP, Simmons VN, Ufondu CB, Ravindra C, Schultz I, Roetzheim RG, Shibata D, Meade CD, Gwede CK. Davis SN, et al. Cancer. 2017 Apr 15;123(8):1390-1400. doi: 10.1002/cncr.30481. Epub 2016 Dec 1. Cancer. 2017. PMID: 27906448 Free PMC article. Clinical Trial.

• Combined Breast and Lung Cancer Screening Among Dual-Eligible Women: A Descriptive Study.

  Yue T, Wong LY, Jani C, Agarwal L, Al Omari O, Aghagoli G, Ahmed A, Bhatt P, Lee A, Lotz M, Marmor H, Paliotti G, Pories S, Richmond J, Shula L, Sandler KL, Conley Thomson C, Backhus LM. Yue T, et al. J Surg Res. 2025 Mar;307:204-211. doi: 10.1016/j.jss.2024.05.024. Epub 2024 Jun 10. J Surg Res. 2025. PMID: 38862305

• Using the Multi-Theory Model (MTM) of Health Behavior Change to Explain the Seeking of Stool-Based Tests for Colorectal Cancer Screening.

  Sharma M, Johansen C, Batra K, Dai CL, Batra R, Hayes T, Singh A. Sharma M, et al. Int J Environ Res Public Health. 2023 Aug 10;20(16):6553. doi: 10.3390/ijerph20166553. Int J Environ Res Public Health. 2023. PMID: 37623139 Free PMC article.

• Lay health educators increase colorectal cancer screening among Hmong Americans: A cluster randomized controlled trial.

  Tong EK, Nguyen TT, Lo P, Stewart SL, Gildengorin GL, Tsoh JY, Jo AM, Kagawa-Singer ML, Sy AU, Cuaresma C, Lam HT, Wong C, Tran MT, Chen MS Jr. Tong EK, et al. Cancer. 2017 Jan 1;123(1):98-106. doi: 10.1002/cncr.30265. Epub 2016 Aug 26. Cancer. 2017. PMID: 27564924 Free PMC article. Clinical Trial.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3